Authors

Oral Selective FGFR3 Inhibition in Urothelial Carcinoma: Opportunities in Intermediate Risk Non-Muscle Invasive Bladder Cancer and Low Grade Upper Tract Urothelial Carcinoma

Study shows gender disparities in CKD detection and treatment

“We observed profound differences in the detection work up and management of chronic kidney disease suggesting suboptimal care among women,” said Juan Jesus Carrero, PharmD, PhD.

Bladder Cancer Advocacy Network (BCAN) announces $600,000 in funding to accelerate breakthroughs in bladder cancer research

Awardees are being recognized for creative approaches to accelerating progress in bladder cancer research.

GNRH agonists vs antagonists in prostate cancer: How to choose

Many factors play into decision-making process when weighing agents.

Malpractice Consult: How attorneys successfully cross-examine expert witnesses

"Effective cross-examination can create an implication that an expert’s opinions are motivated by bias or self-interest, rather than a neutral evaluation of the facts. This is frequently accomplished by highlighting the fact that experts are paid for time spent reviewing a case and testifying," writes Kenton H. Steele, Esq.

Management of hormone-naïve oligometastatic prostate cancer

Growing evidence supports the existence of an intermediate metastatic disease state.

Integrating video visits into urologic training

"Now is the time for programs to leverage their existing telehealth platforms and practices for trainee education while continuing to serve patients," the authors write.

US Urology Partners Names Healthcare Visionary Raoul S. Concepcion, MD, as Chief Science Officer

Concepcion is editor-in-chief of Urology Times' sister publication, Urologists in Cancer Care.

Letter: Declassifying Gleason 6 as a cancer would do more harm than good

"We feel a more appropriate approach would be to retain true Gleason 6 as a cancer of extremely low metastatic potential requiring close follow-up," write Harris et al.

PINNACLE trial aims to confirm pilot success with BPH drug-coated balloon catheter

The drug-coated balloon catheter system is being compared with a sham device in a double-blinded randomized trial.

A physician’s advice for defusing patient anger

Rebekah Bernard, MD, provides tips for improving interactions with patients who are angry.

Urology Practice advice: prioritize billing and coding oversight

When a miscoded procedure is the result of substantial negligence or fraud, it can be detrimental to a medical practice or physician.

PARP inhibitors: Treating mCRPC from a genetic basis

Treatments provide a targeted therapeutic strategy for metastatic castration-resistant prostate cancer.

Urologic Consultants has joined Solaris Health

Leading West Michigan practice now affiliated with nation’s largest urological healthcare management company

Radical nephrectomy before or after systemic therapy for mRCC

Recent research has revived the controversy regarding the role of cytoreductive nephrectomy in this setting.

Money Matters: How can you plan for your retirement income needs?

"Don’t forget that the cost of living will go up over time, and keep in mind that your retirement expenses may change from year to year," writes Ronald J. Paprocki, JD, CFP, CHBC.

How text messaging can be a valuable tool for your practice

Here are seven ways texting can improve healthcare revenue and decrease costs.

Integrating video visits into urologic training

"Now is the time for programs to leverage their existing telehealth platforms and practices for trainee education while continuing to serve patients," the authors write.

New Drug Application initiated with FDA for TAR-200 for NMIBC

The NDA is supported by data from cohort 2 of the phase 2b SunRISe-1 trial.

Online reviews are crucial to maintaining a thriving health care practice

Independent health care practices rely on online ratings and reviews to attract new patients and establish themselves as leading, recognizable providers in their community.

Managing your online reputation in health care

While online reviews are critical in any industry, patient expectations are simply different when it comes to health care.

Register Today! UH Urology Institute’s Fall Symposiums

University Hospitals Urology Institute is excited to announce that this coming fall, the department is hosting 2 educational courses in cutting-edge urologic specialties: female sexual health and gender care.

Allina Health Cancer Institute 2022 Symposium reimagines cancer care

The symposium brings together clinicians devoted to solving the disease of cancer and the many challenges associated with it.

The role of surgery continues to evolve in seminoma

"RPLND is an attractive option for those who prefer to avoid chemotherapy," write Jiping Zeng, MD; Timothy A. Masterson, MD; and Clint Cary, MD, MPH, MBA.

Letter: Declassifying Gleason 6 as a cancer would do more harm than good

"We feel a more appropriate approach would be to retain true Gleason 6 as a cancer of extremely low metastatic potential requiring close follow-up," write Harris et al.

KEYNOTE-B15: EV/pembro sets new benchmark before cystectomy in MIBC

“Neoadjuvant and adjuvant EV/pembro significantly improved event-free survival, overall survival, and path CR rate vs neoadjuvant gem/cis in patients with muscle-invasive bladder cancer who are eligible for cisplatin-based chemotherapy and radical cystectomy," said Matthew D. Galsky, MD.

Abiraterone-based triplet boosts survival in de novo mCSPC

Findings from the PEACE-1 trial published in the Lancet showed that adding abiraterone acetate and prednisone to androgen-deprivation therapy and docetaxel improved overall survival in patients with de novo metastatic castration-sensitive prostate cancer.

Smaller medical practices increasingly targeted for cyber attacks

Patient data is so valuable — and smaller providers are more vulnerable — that hackers are increasingly targeting physician groups.

The aging surgeon: A geriatrician's perspective

"We all need to revisit meaningful methods for ongoing assurance of competency specific to our fields of medicine and surgery across the physician career span," writes Hal H. Atkinson, MD, MS.

Novel intravesical drug delivery systems explored in bladder cancer

"TAR-200 is a sort of a pretzel device. It's a novel drug delivery mechanism that's placed inside the bladder for sustained release of gemcitabine," explains Siamak Daneshmand, MD.